BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 24239175)

  • 21. CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases.
    Yopp AC; Shia J; Butte JM; Allen PJ; Fong Y; Jarnagin WR; DeMatteo RP; D'Angelica MI
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S339-46. PubMed ID: 21584832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P-glycoprotein activity predicts outcome in childhood acute lymphoblastic leukemia.
    Brozek J; Bryl E; Płoszyńska A; Balcerska A; Witkowski JM
    J Pediatr Hematol Oncol; 2009 Jul; 31(7):493-9. PubMed ID: 19564743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CXCR4 indicates poor prognosis in patients with clear cell carcinoma of the ovary.
    Sekiya R; Kajiyama H; Sakai K; Umezu T; Mizuno M; Shibata K; Yamamoto E; Fujiwara S; Nagasaka T; Kikkawa F
    Hum Pathol; 2012 Jun; 43(6):904-10. PubMed ID: 22169254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring.
    Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M
    Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases.
    Mi JQ; Wang X; Yao Y; Lu HJ; Jiang XX; Zhou JF; Wang JH; Jiao B; Shen SH; Tang JY; Gu LJ; Jiang H; Ma LY; Hao SG; Chen FY; Xiong SM; Shen ZX; Chen Z; Chen B; Chen SJ
    Leukemia; 2012 Jul; 26(7):1507-16. PubMed ID: 22297722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
    Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
    J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Micro-RNA-16 expression in paraffin-embedded specimen correlates with overall survival of T-lymphoblastic lymphoma/leukemia.
    Xi Y; Li J; Zan L; Wang J; Wang G; Ning Y
    Hum Pathol; 2013 Jun; 44(6):1011-6. PubMed ID: 23260326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
    Möricke A; Lauten M; Beier R; Odenwald E; Stanulla M; Zimmermann M; Attarbaschi A; Niggli F; Schrappe M
    Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence.
    Wu S; Korte A; Gessner R; Henze G; Seeger K
    Cancer; 2003 Aug; 98(3):625-31. PubMed ID: 12879482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma.
    Laverdiere C; Hoang BH; Yang R; Sowers R; Qin J; Meyers PA; Huvos AG; Healey JH; Gorlick R
    Clin Cancer Res; 2005 Apr; 11(7):2561-7. PubMed ID: 15814634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Fas ligand in newly diagnosed childhood acute lymphoblastic leukemia.
    Volm M; Zintl F; Sauerbrey A; Koomägi R
    Anticancer Res; 1999; 19(4C):3399-402. PubMed ID: 10629626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia.
    Sauerbrey A; Häfer R; Zintl F; Volm M
    Anticancer Res; 1999; 19(1B):645-9. PubMed ID: 10216470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.
    Elia L; Grammatico S; Paoloni F; Vignetti M; Rago A; Cenfra N; Mecarocci S; Mancini M; Luciani M; Di Raimondo F; Cazzaniga G; Matarazzo M; Moleti ML; Santoro L; Gaidano G; Foà R; Mandelli F; Cimino G
    Am J Hematol; 2011 Dec; 86(12):993-7. PubMed ID: 21953510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early T-cell precursor leukemia/lymphoma in adults and children.
    Allen A; Sireci A; Colovai A; Pinkney K; Sulis M; Bhagat G; Alobeid B
    Leuk Res; 2013 Sep; 37(9):1027-34. PubMed ID: 23827350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.
    Kalina T; Vaskova M; Mejstrikova E; Madzo J; Trka J; Stary J; Hrusak O
    BMC Cancer; 2005 Apr; 5():38. PubMed ID: 15826304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of early treatment response in children with acute lymphoblastic leukemia: a single institution experience in Shanghai, China.
    Tie LJ; Gu LJ; Song DL; Jiang LM; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):5-9. PubMed ID: 19149913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential usage of VLA-4 and CXCR4 by CD3+CD56+ NKT cells and CD56+CD16+ NK cells regulates their interaction with endothelial cells.
    Franitza S; Grabovsky V; Wald O; Weiss I; Beider K; Dagan M; Darash-Yahana M; Nagler A; Brocke S; Galun E; Alon R; Peled A
    Eur J Immunol; 2004 May; 34(5):1333-41. PubMed ID: 15114666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR4 and vascular cell adhesion molecule 1 are key chemokine/adhesion receptors in the migration of cytokine-activated T cells.
    Bryant J; Ahern DJ; Brennan FM
    Arthritis Rheum; 2012 Jul; 64(7):2137-46. PubMed ID: 22275188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of CXCR4 in primary tumor of patients with HER-2 negative breast cancer was predictive of a poor disease-free survival: a validation study.
    Mizell J; Smith M; Li BD; Ampil F; Chu QD
    Ann Surg Oncol; 2009 Oct; 16(10):2711-6. PubMed ID: 19593633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4.
    Gazitt Y; Akay C
    Stem Cells; 2004; 22(1):65-73. PubMed ID: 14688392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.